German medtech startup developing therapies to address urgent medical needs in cancer and infectious diseases using a dual TLR agonist platform that stimulates innate immunity.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €10 M | Mar, 2026 | series-a |
Industries
Frequently Asked Questions
Where is Kupando located?
Kupando is located in Schönefeld, Germany.
What industries does Kupando operate in?
Kupando operates in the following industries: medtech, biotechnology, oncology, infectious diseases.
When was Kupando founded?
Kupando was founded on 2026-03-18.
How much total funding has Kupando raised?
Kupando has raised a total of $10,000,000.
Who are the investors in Kupando?
The investors in Kupando are: Remiges Ventures, LifeCare Partners, Brandenburg Kapital, High-Tech Gruenderfonds, Ventura Biomed Investors, Carma Fund.
What services does Kupando provide?
Kupando offers a comprehensive digital advertising platform that facilitates programmatic buying and selling of ad inventory between advertisers and publishers.
How does Kupando help advertisers reach their target audience?
The platform utilizes advanced targeting technology based on user behavior, demographics, and geographic data to deliver advertisements to the most relevant consumers.
Can publishers monetize their website traffic through Kupando?
Yes, publishers can integrate their websites with the platform to fill their available ad spaces with high-quality advertisements from various global brands.
What ad formats are available on the Kupando platform?
The system supports a wide range of formats including standard display banners, native advertising, video spots, and rich media placements across both desktop and mobile devices.
Is it easy to track campaign performance with Kupando?
Advertisers have access to a real-time dashboard that provides detailed analytics and reporting on key metrics such as impressions, clicks, conversions, and overall return on investment.